The present invention is directed towards the treatment of spinal disorders and pain. More particularly, the present invention is directed to systems and methods of treating the spine, which eliminate pain and enable spinal motion, which effectively mimics that of a normally functioning spine.
The superior vertebra with its inferior facets, the inferior vertebra with its superior facet joints, the intervertebral disc, and seven spinal ligaments (not shown) extending between the superior and inferior vertebrae together comprise a spinal motion segment or functional spine unit. Each spinal motion segment enables motion along three orthogonal axes, both in rotation and in translation. The various spinal motions are illustrated in
Traumatic, inflammatory, metabolic, synovial, neoplastic and degenerative disorders of the spine can produce debilitating pain that can affect a spinal motion segment's ability to properly function. The specific location or source of spinal pain is most often an affected intervertebral disc or facet joint. Often, a disorder in one location or spinal component can lead to eventual deterioration or disorder, and ultimately, pain in the other.
Spine fusion (arthrodesis) is a procedure in which two or more adjacent vertebral bodies are fused together. It is one of the most common approaches to alleviating various types of spinal pain, particularly pain associated with one or more affected intervertebral discs. While spine fusion generally helps to eliminate certain types of pain, it has been shown to decrease function by limiting the range of motion for patients in flexion, extension, rotation and lateral bending. Furthermore, the fusion creates increased stresses on adjacent non-fused motion segments and accelerated degeneration of the motion segments. Additionally, pseudarthrosis (resulting from an incomplete or ineffective fusion) may not provide the expected pain-relief for the patient. Also, the device(s) used for fusion, whether artificial or biological, may migrate out of the fusion site creating significant new problems for the patient.
Various technologies and approaches have been developed to treat spinal pain without fusion in order to maintain or recreate the natural biomechanics of the spine. To this end, significant efforts are being made in the use of implantable artificial intervertebral discs. Artificial discs are intended to restore articulation between vertebral bodies so as to recreate the full range of motion normally allowed by the elastic properties of the natural disc. Unfortunately, the currently available artificial discs do not adequately address all of the mechanics of motion for the spinal column.
It has been found that the facet joints can also be a significant source of spinal disorders and debilitating pain. For example, a patient may suffer from arthritic facet joints, severe facet joint tropism, otherwise deformed facet joints, facet joint injuries, etc. These disorders lead to spinal stenosis, degenerative spondylolithesis, and/or isthmic spondylolisthesis, pinching the nerves that extend between the affected vertebrae.
Current interventions for the treatment of facet joint disorders have not been found to provide completely successful results. Facetectomy (removal of the facet joints) may provide some pain relief; but as the facet joints help to support axial, torsional, and shear loads that act on the spinal column in addition to providing a sliding articulation and mechanism for load transmission, their removal inhibits natural spinal function. Laminectomy (removal of the lamina, including the spinal arch and the spinous process) may also provide pain relief associated with facet joint disorders; however, the spine is made less stable and subject to hypermobility. Problems with the facet joints can also complicate treatments associated with other portions of the spine. In fact, contraindications for disc replacement include arthritic facet joints, absent facet joints, severe facet joint tropism, or otherwise deformed facet joints due to the inability of the artificial disc (when used with compromised or missing facet joints) to properly restore the natural biomechanics of the spinal motion segment.
While various attempts have been made at facet joint replacement, they have been inadequate. This is due to the fact that prosthetic facet joints preserve existing bony structures and therefore do not address pathologies that affect facet joints themselves. Certain facet joint prostheses, such as those disclosed in U.S. Pat. No. 6,132,464, are intended to be supported on the lamina or the posterior arch. As the lamina is a very complex and highly variable anatomical structure, it is very difficult to design a prosthesis that provides reproducible positioning against the lamina to correctly locate the prosthetic facet joints. In addition, when facet joint replacement involves complete removal and replacement of the natural facet joint, as disclosed in U.S. Pat. No. 6,579,319, the prosthesis is unlikely to endure the loads and cycling experienced by the vertebra. Thus, the facet joint replacement may be subject to long-term displacement. Furthermore, when facet joint disorders are accompanied by disease or trauma to other structures of a vertebra (such as the lamina, spinous process, and/or transverse processes) facet joint replacement is insufficient to treat the problem(s).
Most recently, surgical-based technologies, referred to as “dynamic posterior stabilization,” have been developed to address spinal pain resulting from more than one disorder” when more than one structure of the spine have been compromised. An objective of such technologies is to provide the support of fusion-based implants while maximizing the natural biomechanics of the spine. Dynamic posterior stabilization systems typically fall into one of two general categories: posterior pedicle screw-based systems and interspinous spacers.
Examples of pedicle screw-based systems are disclosed in U.S. Pat. Nos. 5,015,247, 5,484,437, 5,489,308, 5,609,636 and 5,658,337, 5,741,253, 6,080,155, 6,096,038, 6,264,656 and 6,270,498. These types of systems involve the use of screws that are positioned in the vertebral body through the pedicle. Certain types of these pedicle screw-based systems may be used to augment compromised facet joints, while others require removal of the spinous process and/or the facet joints for implantation. One such system, the Zimmer Spine Dynesys® employs a cord which is extended between the pedicle screws and a fairly rigid spacer which is passed over the cord and positioned between the screws. While this system is able to provide load sharing and 'restoration of disc height, because it is so rigid, it does not effective in preserving the natural motion of the spinal segment into which it is implanted. Other pedicle screw-based systems employ articulating joints between the pedicle screws. Because these types of systems require the use of pedicle screws, implantation of the systems are often more invasive to implant than interspinous spacers.
Where the level of disability or pain to the affected spinal motion segments is not that severe or where the condition, such as an injury, is not chronic, the use of interspinous spacers are preferred over pedicle based systems as they require a less invasive implantation approach and less dissection of the surrounding tissue and ligaments. Examples of interspinous spacers are disclosed in U.S. Pat. Nos. Re. 36,211, U.S. Pat. Nos. 5,645,599, 6,149,642, 6,500,178, 6,695,842, 6,716,245 and 6,761,720. The spacers, which are made of either a hard or compliant material, are placed in between adjacent spinous processes. The harder material spacers are fixed in place by means of the opposing force caused by distracting the affected spinal segment and/or by use of keels or screws that anchor into the spinous process. While slightly less invasive than the procedures required for implanting a pedicle screw-based dynamic stabilization system, implantation of hard or solid interspinous spacers still requires dissection of muscle tissue and of the supraspinous and interspinous ligaments. Additionally, these tend to facilitate spinal motion that is less analogous to the natural spinal motion than do the more compliant and flexible interspinous spacers. Another advantage of the compliant/flexible interspinous spacers is the ability to deliver them somewhat less invasively than those that are not compliant or flexible; however, their compliancy makes them more susceptible to displacement or migration over time. To obviate this risk, many of these spacers employ straps or the like that are wrapped around the spinous processes of the vertebrae above and below the level where the spacer is implanted. Of course, this requires some additional tissue and ligament dissection superior and inferior to the implant site, i.e., at least within the adjacent interspinous spaces.
With the limitations of current spine stabilization technologies, there is clearly a need for an improved means and method for dynamic posterior stabilization of the spine that address the drawbacks of prior devices. In particular, it would be highly beneficial to have a dynamic stabilization system that involves a minimally invasive implantation procedure, where the extent of distraction between the affected vertebrae is adjustable upon implantation and at a later time if necessary. It would be additionally advantageous if the system or device was also removable in a minimally invasive manner.
The present invention provides devices, systems and methods for stabilizing at least one spinal motion segment. The stabilizing devices include an expandable spacer or member having an unexpanded or lower profile configuration and an expanded or higher profile configuration. The unexpanded or lower profile, in certain embodiments, facilitates delivery of the device to an implant site by reducing the space requirements for such delivery. In an expanded or higher profile configuration, the spacer device has a size, volume, diameter, length, cross-section and/or shape configured for positioning between the spinous processes of adjacent vertebrae in order to engage the vertebrae and/or distract the vertebrae relative to each other. Still yet, the expanded profile of the device may be further extended if necessary as elaborated on below.
In certain embodiments, the spacer or expandable member is a balloon made of either non-compliant or compliant material which may be porous or non-porous, or may include a mesh material which may be coated or lined with a porous or non-porous material. The material may define a cavity which is fillable with an inflation and/or expansion medium for inflating and/or expanding the expandable member. The device may further include a port for coupling to a source of inflation/expansion medium. In certain embodiments, the port may be used to deflate or evacuate the expandable member.
In other embodiments, the spacer or expandable members are cages, struts, wires or solid objects having a first or unexpanded shape (having a lower profile) which facilitates delivery to the implant site and a second or expanded shape (having a larger profile) which facilitates distraction between vertebrae. The devices may have annular, spherical, cylindrical, cross, “X”, star or elliptical shapes when in an expanded condition and/or unexpanded condition. The expandable members may be self-expanding or adjustably expandable depending on the extent of distraction required. Certain of the devices may be further extended once in an expanded state. For example, the height dimension of the device, or that dimension which affects distraction between adjacent vertebrae and/or spinous processes, may be further increased upon expansion in order to achieve the amount of distraction desired.
The stabilizing devices may be configured such that the transformation from the low-profile state to the high-profile state is immediate or gradual, where the extent of expansion is controllable. The transformation may occur in multiple discrete steps (i.e., extension of a dimension after the device is in an expanded state), in one-step, or evolve in a continuous fashion where at least one of volume, shape, size, diameter, length, etc. until the desired expansion end point is achieved in order to accommodate the size of the interspinous implant space and/or the amount of distraction desired between adjacent vertebrae. In certain embodiments, a minimum expanded or high-profile state is initially achieved with the option to further expand or extend the high-profile state to accommodate the particular space requirements or distraction objectives of the implant site.
This transformation may be reversible such that after implantation, the stabilizing device may be partially or completely unexpanded, collapsed, compressed, retracted, deflated or at least reduced in size, volume, etc. in order to facilitate removal of the member from the implant site or to facilitate adjustment or repositioning of the member in vivo.
The stabilizing devices may be configured to stay stationary in the implant site on their own (or “float”) or maybe further fixed or anchored to surrounding tissue, e.g., bone (e.g., spinous processes, vertebrae), muscle, ligaments or other soft tissue, to ensure against migration of the implant. In their final deployed state, the stabilizing devices may be flexible to allow some degree of extension of the spine or may otherwise be rigid so as prevent extension altogether. Optionally, the devices may include one or more markers on a surface of the expandable member to facilitate fluoroscopic imaging.
The invention further includes systems for stabilizing at least one spinal motion segment which include one or more of the expandable members as described above. For spacers having a balloon configuration, the systems may further include an expansion medium for injection within or for filling the interior of the expandable member via the port. For expandable members which are expandable by mechanical means or actuation, the systems may further include delivery mechanisms to which the stabilizing spacers are attached which, when actuated or released from the stabilizing device, cause the device to expand or deploy.
The subject systems may further include at least one means for anchoring or securing the expandable member to the spinal motion segment to prevent migration of the device from the implant site. In certain embodiments, the securing means is a screw or the like for penetrating bone, where the spacer is configured to receive or partially constrain the screw. The device may then be anchored or secured to a bony structure of the vertebrae, such as one of the spinous processes between which it is implanted. The device may be further configured to be anchored to a bony structure of both vertebrae between which it is implanted and, as such, function to “fuse” the vertebrae together. Such capability would allow a physician to convert a spinal stabilization procedure to a fusion procedure if, upon commencing the implant procedure, the spinal motion segment being treated is observed to require such. Alternatively, such a device would allow a fusion procedure to be performed subsequently (e.g., months or years later) to the dynamic stabilization procedure should the affected spinal motion segment degenerate further. Without having to remove the device and/or implant additional components (other than bone screws or the like), trauma to the patient and the cost of the procedure is greatly minimized.
The invention further includes methods for stabilizing at least one spinal motion segment which involve the implantation of one or more devices or expandable spacers of the present invention, in which the expandable member is positioned between the spinous processes of adjacent vertebrae in an unexpanded or undeployed condition and then subsequently expanded or deployed to a size and/or shape for selectively distracting the adjacent vertebrae. The invention also contemplates the temporary implantation of the subject devices which may be subsequently removed from the patient once the intended treatment is complete. The methods may also include adjustment of the implants in vivo.
Many of the methods involve the percutaneous implantation of the subject devices from either an ipsilateral approach or a mid-line approach into the interspinous space. Certain methods involve the delivery of certain components by a lateral approach and other components by a mid-line approach. The implantation methods may involve the use of cannulas through which the stabilizing devices are delivered into an implant site, however, such may not be required, with the stabilizing devices being configured to pass directly through an incision.
These and other objects, advantages, and features of the invention will become apparent to those persons skilled in the art upon reading the details of the invention as more fully described below.
The invention is best understood from the following detailed description when read in conjunction with the accompanying drawings. It is emphasized that, according to common practice, the various features of the drawings are not to-scale. On the contrary, the dimensions of the various features are arbitrarily expanded or reduced for clarity. Included in the drawings are the following figures:
FIGS. 29A and 29A′ illustrate perspective and front views of another interspinous spacer device of the present invention in an undeployed state.
FIGS. 29B and 29B′ illustrate perspective and front views of the interspinous spacer device of
FIGS. 29C and 29C′ illustrate perspective and front views of the interspinous spacer device of
FIGS. 29D and 29D′ illustrate perspective and front views of the interspinous spacer device of
FIGS. 30A and 30A′ illustrate perspective and front views of another interspinous spacer device of the present invention in a fully deployed state.
FIGS. 30B and 30B′ illustrate perspective and side views of the interspinous spacer device of
FIGS. 30C and 30C′ illustrate perspective and side views of the interspinous spacer device of
Before the subject devices, systems and methods are described, it is to be understood that this invention is not limited to particular embodiments described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present invention will be limited only by the appended claims.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
It must be noted that as used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a spinal segment” may include a plurality of such spinal segments and reference to “the screw” includes reference to one or more screw and equivalents thereof known to those skilled in the art, and so forth.
Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limits of that range is also specifically disclosed. Each smaller range between any stated value or intervening value in a stated range and any other stated or intervening value in that stated range is encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included or excluded in the range, and each range where either, neither or both limits are included in the smaller ranges is also encompassed within the invention, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the invention.
All publications mentioned herein are incorporated herein by reference to disclose and describe the methods and/or materials in connection with which the publications are cited. The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present invention is not entitled to antedate such publication by virtue of prior invention. Further, the dates of publication provided may be different from the actual publication dates which may need to be independently confirmed.
The present invention will now be described in greater detail by way of the following description of exemplary embodiments and variations of the devices and methods of the present invention. The invention generally includes an interspinous spacer device as well as instruments for the percutaneous implantation of the interspinous spacer. A key feature of the interspinous spacer device is that it is expandable from a low profile configuration to a higher profile or operative configuration. This design allows the device, when in the low profile condition, to be delivered by percutaneous means without requiring the removal of any portion of the spinal motion segment into which the device is implanted.
As mentioned above, certain of the devices include balloon embodiments or those having expandable cavities which are expandable by the introduction of an inflation or expansion medium therein. Many of these are illustrated in
Referring now to the drawings and to
Those spacers made of an inflatable non-porous material, i.e., balloon type spacers (see
Other embodiments of the subject spacers are made of an expandable mesh or cage (see
In certain embodiments of present invention, either during the implant procedure or in a subsequent procedure, the size or volume of the implanted expandable spacer may be selectively adjusted or varied. For example, after an initial assessment upon implant, it may be necessary to adjust, either reduce or increase, the size or volume of the spacer to optimize the intended treatment. Further, it may be intended to only temporarily implant the spacer for the purpose of treating a temporary condition, e.g., an injured or bulging or herniated disk. Once the repair is achieved or the treatment completed, the spacer may be removed, either with or without substantially reducing the size or volume of the spacer. In other embodiments, the spacer as well as the inflation/expansion material may be made of biodegradable materials wherein the spacer degrades after a time in which the injury is healed or the treatment completed.
When unexpanded or deflated, as shown in
For those embodiments of expandable bodies which comprise a balloon configuration, balloon 34 has an inflation or injection port 32 at a sidewall 30 for coupling to a source of inflation or expansion material or medium. Port 32 may consist of a one-way valve which is self-sealing upon release from an inflation mechanism or tube 76. Port 32 is further configured to releasably engage from tube 76, where such engagement may be threaded or involve a releasable locking mechanism. Where the expandable body comprises a mesh or cage, port 32 simply acts as an exit port, however, where an expansion material is used, it also functions as an injection port for the expansion material.
Optionally, device 24 may include a pair of tabs 36 which may be positioned on one side of the device where the tabs 36 are preferably situated at the apexes 28 of expandable body 34. Pins or screws (not yet shown) may be used to secure the tabs against the spinous process to further ensure long-term retention of device 24 within the implant site. Tabs 36 are made of a biocompatible material, such as latex, acrylate, rubber, or a metal, and may be made of the same material used for the expandable member 34. Shown here attached to tabs 36 are tethers 38 which are used in part to manipulate the positioning of expandable body 34 upon implantation into the targeted spinal motion segment. The tethers may be made of any suitable material including but not limited to materials used to make conventional sutures. They may also be made of a biodegradable material. While two tabs and associated tethers are provided in the illustrated embodiment, one, three or more may be employed, where the respective tabs are located on the expandable body so as to be adjacent a bony structure of the vertebra suitable for anchoring thereto. In embodiments which do not employ securing tabs 36, tethers 38 may be attached directly to the expandable body itself.
Optionally still, device 24 may further include radiopaque markers 40 on the surface of expandable body 34 visible under fluoroscopic imaging to facilitate positioning of the expandable body. Any number of markers 40 may be employed anywhere on expandable body 34, however, as few as four markers, one at each apex, may be sufficient. With embodiments employing cage or mesh expandable bodies, the cage or mesh material itself may be radiopaque.
A system of the present invention includes a cannula device 70 having an outer sheath 72, a proximal hub 78 and preferably at least two interior lumens 74, 76 for the percutaneous delivery the device and other tools for implanting the device, which tools may include a cutting instrument 62 (see
In
As illustrated in
The preloading of device 24 to delivery instrument 76 involves providing expandable body 34 in an unexpanded or deflated state and releasably coupled, as described above, by way of inflation or injection port 32 of expandable body 34 to the distal end of delivery instrument 76. In addition to functioning as a pusher, instrument 76 may act as an inflation lumen for balloon type embodiments through which an inflation medium is transported to within expandable body 34.
Depending upon the material used to fabricate expandable body 34, the expandable body may have a degree of stiffness in an unexpanded or deflated state such that it may maintain an elongated configuration so as to be directly insertable and pushable through cannula 70. This may be the case where the expandable member 34 is made of a cage or mesh material. Alternatively, a pusher or small diameter rod (not shown) may be inserted through inflation port 32 to within expandable body 34 to keep it in an elongated state so as to prevent expandable body 34 from bunching within cannula 70 and to provide some rigidity to more effectively position the expandable body in the target implant site. The rod is then removed from expandable body 34 and from delivery device 76 upon positioning the expandable body at the target implant site. In either case, expandable body 34 is folded or compressed about its minor axis with the side wall opposite the inflation port 32 defining a distal end 25 (see
Once interspinous device 24 is preloaded to delivery device 76 as just described, device 24 is then inserted into a lumen of cannula 70 with tethers 38 pulled back and trail proximally so that the tether ends 38a extend from hub 78 of cannula 70. Expandable body member 34 is translated through cannula 70 to within opening 58 within spinous ligament 54 as best illustrated in
Once centrally positioned, expandable body 34 is inflated or expanded, as illustrated in
With embodiments in which the expandable body is initially inflated with air and then filled with a solid or fluid medium, the latter is preferably not delivered or injected into the interior of the expandable body until the position of the expandable body within the interspinous space has been verified and optimized. This is beneficial in situations where, upon inflation, it is found that the expandable body is misaligned within the interspinous space and requires repositioning. The expandable body may simply be deflated of air to the extent necessary and repositioned in a less inflated or deflated state. If necessary, for example where it is found that the maximum spacer or expandable body size is insufficient for the particular application at hand, expandable body 34 may be completely deflated and removed and replaced with a more suitably sized unit.
For balloon spacers and those mesh spacers which are not by themselves sufficiently self-retaining, once the position and extent of inflation or expansion of expandable body 34 are optimized, the expansion medium, e.g., polyurethane, is allowed to flow or injected into the interior of the expandable body via port 32. As illustrated in
The extent of possible distraction maybe limited by the capacity of expandable body 34 and the type of expandable body material employed. In certain embodiments, such as expandable bodies made of non-compliant or semi-compliant balloons, the requisite volume of the inflation medium may be substantially fixed whereby the balloon achieves its fully expanded configuration upon filling it with the fixed volume of medium. In other embodiments, such as with balloons made of a compliant material, the extent of expansion may be variable and selectable intraoperatively depending on the extent of lordosis or distraction to be achieved between the spinous processes in which balloon 34 is now interposed.
Upon achieving the desired distraction between the vertebrae, inflation/expansion lumen 76 is disengaged from expandable body port 32 which then becomes sealed by means of a one-way valve that is closed upon disengagement of lumen 76. Inflation/expansion lumen is then removed from cannula 70. While the opposing compressive force exerted on expandable body 34 by the distracted spinous processes 18, 22 may be sufficient to permanently retain expandable body 34 therebetween, the interspinous device may be further secured to the spinous processes 18, 22 to ensure that the expandable body does not slip or migrate from its implanted position. To this end, tabs 36 are anchored to the spinous processes as illustrated in
To ensure accurate placement of screws 90, along with instrument 88, can be tracked and translated over respective tethers 38, which function as guide wires. By manipulating instrument 88, the screws are driven or screwed into the respective spinous process. Screwdriver 88 is then disengaged or unscrewed from screw 90. After both tabs 36 are securely anchored to the spinous processes, the screwdriver and the cannula may be removed from the patient's back.
While certain of the expandable spacers are intended to be permanently implanted within a spine, certain others may be implanted only temporarily to facilitate the healing of an injury or the treatment of a reversible or non-chronic condition, such as a herniated disk. For such temporary treatments, the expansion material most likely is a fluid, such as saline, which may be easily aspirated through port 32 or may be allowed to drain out via a penetration or cut made in the expandable member. In those embodiments in which the expansion material is a flowable solid, which may or may not subsequently harden within the expandable member, the material may be one that is reconstitutable into a liquid form which may then be subsequently aspirated or evacuated from the expandable member. For percutaneous removal of the expandable member, a cannula such as cannula 70 may be used and an aspiration instrument delivered therethrough and coupled to port 32. After deflation and/or evacuation of the expandable member, and removal of the tacks, sutures, staples, etc. if such are used to secure tabs 36, the expandable member may be easily removed through cannula 70. With biodegradable spacers, removal of the spacer is obviated.
It should be noted that any of the above-described steps or procedures, including but not limited to cannulation of the target area, dissection of the spinous ligament, insertion of the expandable body within the dissected opening of the spinous ligament, inflation and/or expansion of the expandable body, adjustment or readjustment of the expandable body, and anchoring of the tabs, etc., may be facilitated by way of a scope 62 delivered through a lumen of cannula 70 to the open distal tip of cannula 70. Alternatively, a second cannula delivered through, another percutaneous penetration may be employed for use of an endoscope and any other instruments needed to facilitate the procedure.
After the desired amount of distraction is achieved between vertebrae 2 and 4, an implantable expandable member 110 of the present invention is delivered adjacent the distracted spinal motion segment. Expandable member 110 may be delivered from the same incision and side as distraction mechanism 100 (ipsilateral approach) and as well as through the same working channel, or may be delivered through a different incision on the same or opposing side of the spinal motion segment being treated (bilateral approach) using two different working channels. In the illustrated embodiment, expandable member 110 is delivered from the same side of the spinous process as distraction mechanism 100. Expandable member 110 may be delivered through a separate designated lumen in cannula 70 and translated distally of hub 104b of distraction mechanism 100.
As shown in
In addition to the expandable balloon spacers, the present invention further provides for mechanically expandable spacers such as those illustrated in
In the undeployed state, as illustrated in
In the deployed state, as illustrated in
Any suitable materials may be used to provide a spacer 160 which is provided in a first state or configuration, e.g., the undeployed state illustrated in
Referring now to
As mentioned above, spacer 160 may be provided with an integrated core member or the core member may be detachably provided on the distal end 182 of inner shaft 178. In the first embodiment, distal end 182 of inner shaft 178 is configured to temporarily couple with a proximal end (i.e., the end closest to handle 174) of the core member. In the latter embodiment, the distal end 182 of inner shaft 178 is configured to be inserted into the lumen of tubular member 162, as illustrated in
With either embodiment, retraction of inner shaft 178, as described above, retracts distal hub 166b towards proximal hub 166a and/or advancement of outer shaft 172 advances proximal hub 166a towards distal hub 166b, thereby causing tubular member 162 to be compressed axially, and thus expanded radially, as shown in
The reconfiguration of spacer 160 may be further facilitated by selectively configuring the wall of tubular member 162. For example, the interior or luminal surface of tubular member 162 may be contoured or incorporated with divots or spacers 180 where, upon compression of tubular member 162, the walls of the uncovered portions 164a, 164b of tubular member 162 will more readily fold inward to provide the resulting configuration shown in
As with the previously described spacer, end portions 192a, 192b may be made of a polymer based material or any other material which allows for simultaneous axial shortening and radial expansion when compressed. Blocks 200, 202 have a more rigid configuration in order to distract the adjacent spinous processes which define the interspinous space into which spacer 190 is positioned without substantial compression of central portion 194. As such, the blocks may be made of a rigid polymer material, a metal, ceramics, plastics, or the like. In order to effect radial expansion and axial shortening of central portion 194, the blocks are selectively sized, shaped and arranged such that an inwardly compressive force on end blocks 202 along the longitudinal axis of the spacer forces end blocks 202 together which in turn forces side or lateral blocks 200 outward and away from each other, as illustrated in
When in an undeployed state, as shown in
Another interspinous spacer 210 of the present invention is illustrated in an undeployed/unexpanded state, in an intermediate state during deployment and in a deployed/expanded state in
In an undeployed state, as shown in
Interspinous spacer 230 of
In an undeployed state, as shown in
The end portions and central portions of the compressible spacers described above may be used in any combination. For example, the polymer-based central portion of
In an undeployed state, as shown in
Each of the expandable and/or inflatable interspinous spacers described thus far is particularly configured to be delivered minimally invasively, even percutaneously, from a single incision located laterally to one side (left or right) of the spinal motion segment to be treated. However, the present invention also includes interspinous spacers which are deliverable through a mid-line incision made directly into the interspinous ligament. Examples of such spacers are now described.
Each strut 284 includes one or more blocks 288. Where more than one block 288 per strut is employed, such as with spacer 280 which employs two blocks 288 per strut 284 and spacer 290 of
Spanning between each strut pair 284a and 284b is a strap 286a and 286b, respectively, affixed to the outermost blocks. Straps 286 may be made of any suitable material which is strong enough to maintain distraction between adjacent spinous processes and to endure any frictional wear which it may undergo due to natural spinal motion. The straps may be flexible such that they act as slings, or may be conformable to the spinous processes once in situ. Alternatively, the straps may be non-conforming and rigid with a planar or curved shape depending on the application at hand. Suitable strap materials include but are not limited to polyester, polyethylene, etc.
With reference to
The initial steps of creating a percutaneous puncture and subsequent penetration into the skin 30 and the dissection of the spinous ligament 54 involve many of the same instruments (e.g., K-wire, trocar, cutting instrument, delivery cannula, etc.) and surgical techniques used in the ipsilateral implantation approach described above with respect to
As best illustrated in FIGS. 28A′ and 28A″, when in an undeployed state, spacer 280 has a relatively low profile to facilitate entry into the interspinous space. Once properly positioned within the interspinous space, deployment of the spacer 280 is initiated, as illustrated in
As the struts are radially extended, straps 286a and 286b emerge and they become tauter as the slack in them is gradually reduced by the extension of the struts. Continued deployment of spacer 280 causes straps 286a, 286b to engage with opposing surfaces of spinous processes 18 and 22. The radial extension of the struts is continued, as illustrated in
At this point, the delivery instrument 300 is released from spacer 280 by unscrewing threaded screw 302 from threaded lumen 285 and removing it from the implant site, as illustrated in
Spacer 280 may configured such that the struts are not retractable without active manipulation of delivery instrument 300 to ensure that their extension, and thus the distraction on the spinal motion segment, is maintained. As configured, spacer 280 may be easily repositioned or removed by subsequent insertion of instrument 300 into the interspinous space and operative engagement with the spacer. Instrument 300 is then manipulated to cause retraction of the struts and the straps, reducing the spacer's profile to allow repositioning or removal of the spacer.
Spacer 310 is implantable and deployable by way of a mid-line approach similar to that described above with respect to the spacer of
After the necessary space is created within the interspinous space as described above, spacer 310, which is releasably connected to delivery shaft 320 as described above, is inserted into the space in a fully undeployed sate (see FIGS. 29A and 29A′). Deployment of the spacer is accomplished by proximally pulling on shaft 320 which compresses rear block 312b towards front block 312a. This in turn causes the linkages 314 to pivot about their respective attachment points with superior and inferior lateral structures or blocks 318a and 318b forced away from each other, as illustrated in FIGS. 29B and 29B′. Continued pulling of instrument 320 further expands linkages 314 in a direction transverse to the central axis of spacer 310 and extend straps 316a, 316b towards respective surfaces of the spinous processes. As front and rear blocks 312a and 312b are centrally tapered, defining a bowtie or hourglass configuration, the strut pairs define a centrally tapered profile as the align to their fully deployed position, as best shown in FIGS. 29C′ and 29D′. In the fully deployed state, the spacer's axial member is positioned within the opening affront block 312a and locked to it. Additionally, straps 316a and 316b are firmly engaged against the spinous processes and the contacted vertebra are distracted from each other. Delivery instrument 320 may then be released from spacer 310 and removed from the implant site.
The proximal end 342 of central member 332 is provided with ratcheted grooves which are releasably engaged within the distal end of 352 of delivery instrument 350 (see FIG. 30C′). Front hub 334a is provided with an opening 340 which also has a grooved internal surface for engaging with the grooves of central member 332.
Spacer 330 is implantable and deployable by way of a mid-line approach similar to that described above with respect to the spacer of
Extending between and affixed to each of the top and bottom linkage pairs are brackets or saddles 374 for receiving the inner surfaces of opposing interspinous processes. Brackets 374 have a substantially rigid and flat central portion 374a and relatively flexible lateral portions 374b which are affixed to hinges 370. The rigid, flat central portion 374a facilitates engagement with the interspinous process. The flexible lateral portions 374b and their hinged connections to spacer 360 facilitate folding of the lateral portions 374b when in an undeployed state and allow for adjustment of spacer 360 once in a deployed state, where a least a portion of the adjustment may be self-adjustment by spacer 360 relative to interspinous space into which it is implanted.
Two of the extension pairs (384 and 388) are positioned at a proximal end or side of hub 382 (i.e., “proximal” being defined as that which is closest to the physician user during delivery of the device) and are “folded” in a proximal direction when in an undeployed state. The other two extension pairs (392 and 396) are positioned at a distal end or side of hub 382 and are “folded” in a distal direction when in an undeployed state. Proximal extension members 384,388 may be interconnected to body 382 and/or to each other in a manner which enables them to be moved simultaneously or independently of each other. The same may be true for the distal extension members 392, 396.
Proximal extension members 384 and 388 each include two elongated arms or extensions 386a, 386b and 390a, 390b, respectively, which extend substantially parallel to each other. Extending between each proximal arm pair is a saddle strut, bridge, bracket or saddle 402. Similarly, distal extension members 392 and 396 each include two extensions 394a, 394b and 398a, 398b, respectively, which extend substantially parallel to each other. Extending between each distal extension pair is a saddle, strut or bridge 404. The resulting “U” configurations enable device 380 to be positioned between adjacent interspinous processes, i.e., within an interspinous space.
The individual extension arms may have any angle curvature and/or contouring to facilitate anatomical engagement within the interspinous space and/or to enable a “stacking” arrangement of spacer devices for use in multiple, adjacent interspinous spaces. Additionally, the spacers may include an element which enables them to be interconnected or attached to each other in either a fixed or dynamic fashion (e.g., by vertical overlap or interconnection) to accommodate a multiple level procedure. The configuration, shape, width, length and arm separation distances of the distal and proximal extensions may vary from each other and from device to device, where the particular parameters and dimensions are selected to best fit the anatomy of the particular spine being treated. For example, the particular dimensions may vary between the extension pairs where one pair (e.g., the distal extensions) may primarily function to distract and/or providing load-bearing support to the vertebrae and the other pair (e.g., the proximal extensions) may primarily function to maintain the position of the device and resist migration. In the embodiment of
Each of the distal and proximal extension members may be interconnected to body 382 and/or to each other in a manner which enables them to be moved simultaneously or independently of each other. The extension members may be attached in a spring loaded fashion whereby the natural or biased position of the extension pairs is in a deployed or higher profile state. Alternatively, the extension members may be biased in an undeployed state which may facilitate abandonment, if desired or indicated, of the implant procedure prior to full deployment of the extension members or removal of the device after implantation. Still yet, the manner of attachment may be such to enable or require manual actuation in order to move or deploy the arm pairs and/or to undeploy the arm pairs.
The extension member or arm pairs are movable between at least two states or positions by way of their attachment to block 382, for example, by a hinge means or the like. In certain embodiments, deployment involves rotational movement where the extension member(s) traverses an arc within the range from 0 degrees to about 90 degrees or less with respect to the longitudinal axis defined by block 382. In other embodiments, the extension member(s) traverses an arc within the range from 0 degrees to greater than 90 degrees with respect to the longitudinal axis defined by block 382. The deployment of the device from a low-profile state to a high-profile state may immediate or gradual, where the extent of rotation is controllable. The deployment may occur in multiple discrete steps, in one-step, or evolve in a continuous fashion until the desired angle of deployment is achieved. Additionally, complete or full deployment may further involve the extension of a dimension, e.g., height, after the device is in an expanded state.
To deliver and deploy device 380 within the body, the device is releasably attached to a delivery rod 406 or the like at a proximal end or side, such as attached to body 382 at a location between proximal extension pairs 384 and 388. Device 380 is provided or otherwise placed in its undeployed state as illustrated in
As mentioned above, the extension members may be deployed in stages or be incrementally extended subsequent to deployment. For example, in the illustrated embodiment of
Extending between each arm pair is a strut, bridge, bracket or saddle 422. The resulting “U” configuration of each the extension pairs enables device 410 to receive adjacent interspinous processes and engage the surfaces thereof.
The arm pairs are rotationally movable between at least an undeployed, collapsed or folded state (
Extension pairs 414 and 416 may be interconnected to body 412 and/or to each other in a manner which enables them to be moved simultaneously or independently of each other, as well as in a manner to provide passive deployment and/or vertical extension or, alternatively, active or actuated deployment and/or vertical extension. For example, the extension pairs may be attached in a spring loaded fashion whereby the natural or biased position of the extension pairs is a deployed state, or the manner of attachment may be such to enable manual actuation in order to move the arms.
To deliver and deploy device 410 within the body, the device is releasably attached to a delivery rod 426 or the like at a proximal end or side of body 412. Device 410 is provided or otherwise placed in its undeployed state as illustrated in
The extension member or arm pairs are movable between at least two states or positions by way of their attachment to block 482, for example, by a hinge or pivoting means or the like to provide rotational movement within about a 90° range or more. Two of the extension pairs 484a and 484b, 486a and 486b are positioned at a proximal end or side of hub 482 (i.e., “proximal” being defined as that which is closest to the physician user during delivery of the device) and are “folded” in a proximal direction when in an undeployed state. The other two extension pairs 488a and 488b, 490a and 490b are positioned at a distal end or side of hub 482 and are “folded” in a distal direction when in an undeployed state. As with the spacers configured for a posterior midline implantation approach, the proximal extension arms and the distal extension members may be interconnected to body 482 and/or to each other in a manner which enables them to be moved simultaneously or independently of each other. Actuation of the arms from an undeployed to a deployed state, and vice versa, is accomplished by manipulation of delivery rod 492. As with the above-described spacers, the extension arms may be further extended, either subsequent to or prior to deployment.
Any of the spacers described herein which are configured for implantation through a percutaneous incision, may be so implanted according to a method of the present invention which involves selective dissection of the supraspinous ligament in which the fibers of the ligament are separated or spread apart from each other in manner to maintain as much of the ligament intact as possible. This approach avoids crosswise dissection of or cutting the ligament and thereby reduces healing time and minimizes the amount of instability to the affected spinal segment. While this approach is ideally suited to be performed through a posterior or midline incision, the approach may also be performed through one or more incisions made laterally of the spine.
Other variations and features of the various mechanical spacers described above are covered by the present invention. For example, a spacer device may include only a single extension member or a single pair of extension arms which are configured to receive either the superior spinous process or the inferior spinous process. The surface of the device body opposite the side to which the extension arms are deployed may be contoured or otherwise configured to engage the opposing spinous process wherein the device is sized to be securely positioned in the interspinous space and provide the desired distraction of the spinous processes defining such space. The additional extension of the extension members subsequent to their initial deployment in order to effect the desired distraction between the vertebrae may be accomplished by expanding the body portion of the device instead of or in addition to extending the individual extension members.
The extension arms of the subject device may be configured to be selectively movable subsequent to implantation, either to a fixed position prior to closure of the access site or otherwise enabled or allowed to move in response to normal spinal motion exerted on the device thereafter. The deployment angles of the extension arms may range from less than 90° (relative to the axis defined by the device body) or may extend beyond 90° where each extension member may be rotationally movable within a range which is different from that of the other extension members. Additionally, the individual extension arms may be movable in any direction relative to the strut or bridge extending between an arm pair or relative to the device body in order to provide shock absorption and/or function as a motion limiter, particularly during lateral bending and axial rotation of the spine. The manner of attachment or affixation of the arm to the extension member may be selected so as to provide movement of the extension arms which is passive or active or both.
For example, the extension arm 430, illustrated in
Another variation of a shock absorbing extension arm is provided in
Referring to
The shock absorber component may be configured to provide “dual response” absorption to loads exerted on it.
With any of the extension members described, a cushioning or padding member 468 (see
Referring to
At the initial point of contact shown in
The actuator shaft 564 has formed within a void 580 in which are defined fingers 576, 576′, 578, and 578′. More or less fingers may be employed according to the degree of choice desired in deployment angle for lobes 556 and 558. A nub 577 may also be defined. The fingers and nub cooperate frictionally with pin 562 which is affixed in the body. As the actuator translates distally, i.e., to the left in the figures, pin 562, fixed relative to the actuator shaft, frictionally engages the fingers and can be frictionally “locked” into several deployment positions, generally in positions where the center of the pin 562 is disposed between two fingers longitudinally (along axis 570) or where the center of the pin 562 is disposed between one finger and a wall of void 580 longitudinally (along axis 570), e.g., wall 581. The nub 577 forms a final terminus beyond which the system can not be further deployed.
Spacer 550 may be configured to be adjusted post-implantation, such as more than 24 hours post-implantation or more than 30 days post-implantation. In order to allow adequate engagement of an adjustment device to spacer 550, anchor point 566, anchor point 568 and/or another component of spacer 550 may be treated, e.g. embedded or coated, with a drug or other agent, may include a radioactive source, and/or may be modified with a suitable surface modification process such as a surface energy modification. Alternatively or additionally, anchor point 566, anchor point 568 and/or another component of spacer 550 may include a covering, such as a removable or penetrable elastomeric covering surrounding anchor point 566 or 568, such as to reduce or prevent tissue and other contaminants from interfering with access by an adjustment tool configured to engage with anchor point 566 and/or anchor point 568.]
In an alternative embodiment, spacer 550 includes one or more portions, not shown, whose shape is modified over time. In a first embodiment, the shape-modifying portion includes materials whose geometry and/or other material property changes with temperature, such as a part which is modified as the implant temperature increases to body temperature. In a second embodiment, the shape modifying portion includes materials which bio-degrade over time, such as to provide a first stabilization condition at implantation and a second stabilization condition, e.g., more movement or flexibility, at a time after the implantation.
Reversal of the deployment may be achieved by withdrawing the actuator shaft, i.e., moving the actuator shaft to the right in the figures. Reversal can be accomplished during the initial implantation procedure, or at a later date such as more than 24 hours post-implantation.
Other optional features which may be employed with the subject spacers include the use of biodegradable materials to form the entire spacer structure or one or more portions thereof. In one variation, a rigid spacer structure having biodegradable portions, e.g., extension members or arms, is implanted within an interspinous space or elsewhere to provide temporary fixation of a spinal motion segment. Upon degradation of the biodegradable portions of the spacer, the remaining spacer structure provides dynamic stabilization to that spinal motion segment. In another variation, the spacer device may be made wholly of non-biodegradable materials and configured to be anchored to a bony structure with a biodegradable securing member, e.g., a screw. As such, upon implantation of the spacer and its securement to both vertebrae between which it is implanted, for example, the spacer functions to “fuse” the vertebrae together. Subsequent degradation of the screws will release the fixed interconnection between the spacer and the bone thereby enabling it to dynamically stabilize the spinal motion segment. The half life of the biodegradable material may be selected so as to delay degradation until a minimum level of healing and improvement is achieved.
With other embodiments of the subject spacers, the static-to-dynamic function of the spacers is reversed, i.e., the spacer is initially implanted for dynamically stabilizing a spinal motion segment, and then subsequently converted to fuse that same segment. The spacer may be configured to be anchored or secured to a bony structure of the vertebrae, such as one of the spinous processes between which it is implanted. Such capability would allow a physician to convert a spinal stabilization procedure to a fusion procedure if, upon commencing the implant procedure, the spinal motion segment being treated is observed to require such. Alternatively, such a device would allow a fusion procedure to be performed subsequently (e.g., months or years later) to the dynamic stabilization procedure should the affected spinal motion segment degenerate further. Thus, without having to remove the device and/or implant additional components (other than bone screws or the like), trauma to the patient and the cost of the procedure is greatly minimized.
Visualization markers or the like may be employed at various locations on the spacer for a variety of purposes. For example, markers may be used to ensure proper placement of the spacer prior to deployment. Markers on opposite sides of a spacer body would ensure that the spacer body has been fully advanced within the interspinous space and that it is in a proper rotational alignment to ensure that the extension arms clear the spinous processes when deployed. Linear marks or grooves aligned relative to the spacer body axis may be useful for this purpose. Other markers may be employed on the spacer delivery or insertion tool, for example, on the blades of the cannula of
Various coatings may be employed over the entire surface of the spacer or a portion (a “zoned” area) thereof including but not limited to antibiotics, lubricous materials, stem cells, extracellular matrices, growth factors, etc. For example, a lubricous coating could prevent the implant from “sticking” to bone and facilitate easier implantation.
As mentioned above with respect to
Implant size and/or geometry selection is also facilitated by use of such imaging systems prior to the implantation procedure. The appropriate size and/or geometry of the implant may also be determined by using a temporary implant which can be adjusted in size or shape to determine the ideal size and geometry of the permanent implant to be selected. Alternatively, a selection of temporary implants may be provided and implanted until the one having the suitable size and/or geometry has been determined. Certain other factors including patient-specific parameters may also be taken into consideration when determining the proper implant size and geometry. Relevant patient parameters include but are not limited to anatomical geometry of the patient, the disease state of the patient, the trauma state of the patient and combinations thereof.
The subject devices and systems may be provided in the form of a kit which includes at least one interspinous device of the present invention. A plurality of such devices may be provided where the devices have the same or varying sizes and shapes and are made of the same or varying biocompatible materials. Possible biocompatible materials include polymers, plastics, ceramic, metals, e.g., titanium, stainless steel, tantalum, chrome cobalt alloys, etc. The kits may further include temporary device implants used for sizing a device to be permanently implanted, instruments and tools for implanting the subject devices, including but not limited to, a cannula, a trocar, a scope, a device delivery/inflation/expansion lumen, a cutting instrument, a screw driver, etc., as well as a selection of screws or other devices for anchoring the spacer tabs to the spinous processes. The kits may also include a supply of the expandable body inflation and/or expansion medium. Instructions for implanting the interspinous spacers and using the above-described instrumentation may also be provided with the kits.
The preceding merely illustrates the principles of the invention. It will be appreciated that those skilled in the art will be able to devise various arrangements which, although not explicitly described or shown herein, embody the principles of the invention and are included within its spirit and scope. Furthermore, all examples and conditional language recited herein are principally intended to aid the reader in understanding the principles of the invention and the concepts contributed by the inventors to furthering the art, and are to be construed as being without limitation to such specifically recited examples and conditions. Moreover, all statements herein reciting principles, aspects, and embodiments of the invention as well as specific examples thereof, are intended to encompass both structural and functional equivalents thereof. Additionally, it is intended that such equivalents include both currently known equivalents and equivalents developed in the future, i.e., any elements developed that perform the same function, regardless of structure. The scope of the present invention, therefore, is not intended to be limited to the exemplary embodiments shown and described herein. Rather, the scope and spirit of present invention is embodied by the appended claims.
This application is a continuation of U.S. patent application Ser. No. 11/593,995, filed Nov. 7, 2006, now U.S. Pat. No. 8,425,559, which is a continuation-in-part of U.S. patent application Ser. No. 11/582,874, filed Oct. 18, 2006, now U.S. Pat. No. 8,128,662 entitled “Minimally Invasive Tooling for Delivery of Interspinous Spacer,” which is a continuation-in-part of U.S. patent application Ser. No. 11/314,712, filed Dec. 20, 2005, now U.S. Pat. No. 8,152,837 entitled “Systems and Methods for Posterior Dynamic Stabilization of the Spine,”, which is a continuation-in-part of U.S. patent application Ser. No. 11/190,496, filed Jul. 26 2005, now U.S. Pat. No. 8,409,282, which is a continuation-in-part of U.S. patent application Ser. No. 11/079,006 filed Mar. 10, 2005, now U.S. Pat. No. 8,012,207, which is a continuation-in-part of U.S. patent application Ser. No. 11/052,002, now U.S. Pat. No. 8,317,864, which is a continuation-in-part of U.S. patent application Ser. No. 11/006,502, filed Dec. 6 2004, now U.S. Pat. No. 8,123,807, which is a continuation-in-part of U.S. patent application Ser. No. 10/970,843, filed Oct. 20, 2004, now U.S. Pat. No. 8,167,944, which are incorporated by reference herein in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
2248054 | Becker | Jul 1941 | A |
2677369 | Knowles | May 1954 | A |
3242120 | Steuber | Mar 1966 | A |
3486505 | Morrison | Dec 1969 | A |
3648691 | Lumb et al. | Mar 1972 | A |
3986383 | Petteys | Oct 1976 | A |
4632101 | Freedland | Dec 1986 | A |
4685447 | Iversen et al. | Aug 1987 | A |
4799484 | Smith et al. | Jan 1989 | A |
4863476 | Shepperd | Sep 1989 | A |
4895564 | Farrell | Jan 1990 | A |
5011484 | Breard et al. | Apr 1991 | A |
5015247 | Michelson | May 1991 | A |
5019081 | Watanabe | May 1991 | A |
5059193 | Kuslich | Oct 1991 | A |
5092866 | Breard et al. | Mar 1992 | A |
5178628 | Otsuka et al. | Jan 1993 | A |
5180393 | Commarmond et al. | Jan 1993 | A |
5182281 | Frigola-Constansa et al. | Jan 1993 | A |
5188281 | Fujiwara et al. | Feb 1993 | A |
5192281 | de la Caffiniere | Mar 1993 | A |
5195526 | Michelson | Mar 1993 | A |
5298253 | LeFiles et al. | Mar 1994 | A |
5368594 | Martin et al. | Nov 1994 | A |
5390683 | Pisharodi | Feb 1995 | A |
5415661 | Holmes | May 1995 | A |
5456722 | McLeod et al. | Oct 1995 | A |
5462738 | LeFiles et al. | Oct 1995 | A |
5472452 | Trott | Dec 1995 | A |
5484437 | Michelson | Jan 1996 | A |
5487739 | Aebischer et al. | Jan 1996 | A |
5489308 | Kuslich et al. | Feb 1996 | A |
5496318 | Howland et al. | Mar 1996 | A |
5531748 | de la Caffiniere et al. | Jul 1996 | A |
5549679 | Kuslich | Aug 1996 | A |
5571189 | Kuslich | Nov 1996 | A |
5591165 | Jackson | Jan 1997 | A |
5609634 | Voydeville | Mar 1997 | A |
5609636 | Kohrs et al. | Mar 1997 | A |
5645599 | Samani et al. | Jul 1997 | A |
5654599 | Casper | Aug 1997 | A |
5658337 | Kohrs et al. | Aug 1997 | A |
5674295 | Ray et al. | Oct 1997 | A |
5700264 | Zucherman et al. | Dec 1997 | A |
5725582 | Bevan et al. | Mar 1998 | A |
5741253 | Michelson | Apr 1998 | A |
5762629 | Kambin | Jun 1998 | A |
5836948 | Zucherman et al. | Nov 1998 | A |
5860977 | Zucherman et al. | Jan 1999 | A |
5863948 | Epstein et al. | Jan 1999 | A |
5876404 | Zucherman et al. | Mar 1999 | A |
RE36211 | Nonomura et al. | May 1999 | E |
5904636 | Chen et al. | May 1999 | A |
5904686 | Zucherman et al. | May 1999 | A |
5928207 | Pisano et al. | Jul 1999 | A |
5972015 | Scribner et al. | Oct 1999 | A |
6039761 | Li et al. | Mar 2000 | A |
6045552 | Zucherman et al. | Apr 2000 | A |
6048342 | Zucherman et al. | Apr 2000 | A |
6066154 | Reiley et al. | May 2000 | A |
6068630 | Zucherman et al. | May 2000 | A |
6074390 | Zucherman et al. | Jun 2000 | A |
6080155 | Michelson | Jun 2000 | A |
6080157 | Cathro et al. | Jun 2000 | A |
6090112 | Zucherman et al. | Jul 2000 | A |
6096038 | Michelson | Aug 2000 | A |
6102928 | Bonutti | Aug 2000 | A |
D433193 | Gaw et al. | Oct 2000 | S |
6132464 | Martin et al. | Oct 2000 | A |
6149642 | Gerhart et al. | Nov 2000 | A |
6149652 | Zucherman et al. | Nov 2000 | A |
6152926 | Zucherman et al. | Nov 2000 | A |
6156038 | Zucherman et al. | Dec 2000 | A |
6159215 | Urbahns et al. | Dec 2000 | A |
6179873 | Zientek | Jan 2001 | B1 |
6183471 | Zucherman et al. | Feb 2001 | B1 |
6190387 | Zucherman et al. | Feb 2001 | B1 |
6225048 | Soderberg-Naucler et al. | May 2001 | B1 |
6235030 | Zucherman et al. | May 2001 | B1 |
6238397 | Zucherman et al. | May 2001 | B1 |
6264651 | Underwood et al. | Jul 2001 | B1 |
6264656 | Michelson | Jul 2001 | B1 |
6267765 | Taylor et al. | Jul 2001 | B1 |
6270498 | Michelson | Aug 2001 | B1 |
6280444 | Zucherman et al. | Aug 2001 | B1 |
6312431 | Asfora | Nov 2001 | B1 |
6332882 | Zucherman et al. | Dec 2001 | B1 |
6332883 | Zucherman et al. | Dec 2001 | B1 |
6336930 | Stalcup et al. | Jan 2002 | B1 |
6348053 | Cachia | Feb 2002 | B1 |
6364883 | Santilli | Apr 2002 | B1 |
6371989 | Chauvin et al. | Apr 2002 | B1 |
6375682 | Fleischmann et al. | Apr 2002 | B1 |
6379355 | Zucherman et al. | Apr 2002 | B1 |
6395032 | Gauchet et al. | May 2002 | B1 |
6402740 | Ellis et al. | Jun 2002 | B1 |
6402750 | Atkinson et al. | Jun 2002 | B1 |
6402784 | Wardlaw et al. | Jun 2002 | B1 |
6413228 | Hung et al. | Jul 2002 | B1 |
6419676 | Zucherman et al. | Jul 2002 | B1 |
6419677 | Zucherman et al. | Jul 2002 | B2 |
6440169 | Elberg et al. | Aug 2002 | B1 |
6443988 | Felt et al. | Sep 2002 | B2 |
6447547 | Michelson | Sep 2002 | B1 |
6451019 | Zucherman et al. | Sep 2002 | B1 |
6451020 | Zucherman et al. | Sep 2002 | B1 |
6471976 | Taylor et al. | Oct 2002 | B1 |
6478796 | Zucherman et al. | Nov 2002 | B2 |
6478822 | Leroux et al. | Nov 2002 | B1 |
6500178 | Zucherman et al. | Dec 2002 | B2 |
6514256 | Zucherman et al. | Feb 2003 | B2 |
6530925 | Boudard et al. | Mar 2003 | B2 |
6558333 | Gilboa et al. | May 2003 | B2 |
6565570 | Sterett et al. | May 2003 | B2 |
6572617 | Senegas et al. | Jun 2003 | B1 |
6575981 | Boyd et al. | Jun 2003 | B1 |
6579319 | Goble et al. | Jun 2003 | B2 |
6582433 | Yun | Jun 2003 | B2 |
6582451 | Marucci et al. | Jun 2003 | B1 |
6599292 | Ray | Jul 2003 | B1 |
6610065 | Branch et al. | Aug 2003 | B1 |
6610091 | Reiley | Aug 2003 | B1 |
6626944 | Taylor et al. | Sep 2003 | B1 |
6645207 | Dixon et al. | Nov 2003 | B2 |
6645211 | Magana | Nov 2003 | B2 |
6652527 | Zucherman et al. | Nov 2003 | B2 |
6652534 | Zucherman et al. | Nov 2003 | B2 |
6663637 | Dixon et al. | Dec 2003 | B2 |
6679886 | Weikel et al. | Jan 2004 | B2 |
6695842 | Zucherman et al. | Feb 2004 | B2 |
6699246 | Zucherman et al. | Mar 2004 | B2 |
6699247 | Zucherman et al. | Mar 2004 | B2 |
6702847 | DiCarlo | Mar 2004 | B2 |
6712819 | Zucherman et al. | Mar 2004 | B2 |
6716245 | Pasquet et al. | Apr 2004 | B2 |
6733534 | Sherman | May 2004 | B2 |
6746485 | Zucherman et al. | Jun 2004 | B1 |
6761720 | Senegas | Jul 2004 | B1 |
6783529 | Hover et al. | Aug 2004 | B2 |
6783546 | Zucherman et al. | Aug 2004 | B2 |
6796983 | Zucherman et al. | Sep 2004 | B1 |
6835205 | Atkinson et al. | Dec 2004 | B2 |
6840944 | Suddaby | Jan 2005 | B2 |
6858029 | Yeh | Feb 2005 | B2 |
6869398 | Obenchain et al. | Mar 2005 | B2 |
6875212 | Shaolian et al. | Apr 2005 | B2 |
6902566 | Zucherman et al. | Jun 2005 | B2 |
6926728 | Zucherman et al. | Aug 2005 | B2 |
6946000 | Senegas et al. | Sep 2005 | B2 |
6949123 | Reiley | Sep 2005 | B2 |
6966930 | Arnin et al. | Nov 2005 | B2 |
6974478 | Reiley et al. | Dec 2005 | B2 |
7011685 | Arnin et al. | Mar 2006 | B2 |
7029473 | Zucherman et al. | Apr 2006 | B2 |
7033358 | Taylor et al. | Apr 2006 | B2 |
7048736 | Robinson et al. | May 2006 | B2 |
7070598 | Lim et al. | Jul 2006 | B2 |
7083649 | Zucherman et al. | Aug 2006 | B2 |
7087055 | Lim et al. | Aug 2006 | B2 |
7087083 | Pasquet et al. | Aug 2006 | B2 |
7097648 | Globerman et al. | Aug 2006 | B1 |
7101375 | Zucherman et al. | Sep 2006 | B2 |
7163558 | Senegas et al. | Jan 2007 | B2 |
7179225 | Shluzas et al. | Feb 2007 | B2 |
7187064 | Tzu et al. | Mar 2007 | B2 |
7189234 | Zucherman et al. | Mar 2007 | B2 |
7189236 | Taylor et al. | Mar 2007 | B2 |
7201751 | Zucherman et al. | Apr 2007 | B2 |
7217291 | Zucherman et al. | May 2007 | B2 |
7223289 | Trieu et al. | May 2007 | B2 |
7229441 | Trieu et al. | Jun 2007 | B2 |
7238204 | Le Couedic et al. | Jul 2007 | B2 |
7252673 | Lim | Aug 2007 | B2 |
7273496 | Mitchell | Sep 2007 | B2 |
7282063 | Cohen et al. | Oct 2007 | B2 |
7297162 | Mujwid | Nov 2007 | B2 |
7306628 | Zucherman et al. | Dec 2007 | B2 |
7318839 | Malberg et al. | Jan 2008 | B2 |
7320707 | Zucherman et al. | Jan 2008 | B2 |
7335200 | Carli | Feb 2008 | B2 |
7335203 | Winslow et al. | Feb 2008 | B2 |
7354453 | McAfee | Apr 2008 | B2 |
7384340 | Eguchi et al. | Jun 2008 | B2 |
7410501 | Michelson | Aug 2008 | B2 |
7442208 | Mathieu et al. | Oct 2008 | B2 |
7445637 | Taylor | Nov 2008 | B2 |
7473268 | Zucherman et al. | Jan 2009 | B2 |
7476251 | Zucherman et al. | Jan 2009 | B2 |
7481839 | Zucherman et al. | Jan 2009 | B2 |
7481840 | Zucherman et al. | Jan 2009 | B2 |
7491204 | Marnay et al. | Feb 2009 | B2 |
7497859 | Zucherman et al. | Mar 2009 | B2 |
7503935 | Zucherman et al. | Mar 2009 | B2 |
7504798 | Kawada et al. | Mar 2009 | B2 |
7510567 | Zucherman et al. | Mar 2009 | B2 |
7520887 | Maxy et al. | Apr 2009 | B2 |
7520899 | Zucherman et al. | Apr 2009 | B2 |
7547308 | Bertagnoli et al. | Jun 2009 | B2 |
7549999 | Zucherman et al. | Jun 2009 | B2 |
7550009 | Arnin et al. | Jun 2009 | B2 |
7565259 | Sheng et al. | Jul 2009 | B2 |
7572276 | Lim et al. | Aug 2009 | B2 |
7575600 | Zucherman et al. | Aug 2009 | B2 |
7585313 | Kwak et al. | Sep 2009 | B2 |
7585316 | Trieu | Sep 2009 | B2 |
7588588 | Spitler et al. | Sep 2009 | B2 |
7591851 | Winslow et al. | Sep 2009 | B2 |
7601170 | Winslow et al. | Oct 2009 | B2 |
7621939 | Zucherman et al. | Nov 2009 | B2 |
7635377 | Zucherman et al. | Dec 2009 | B2 |
7635378 | Zucherman et al. | Dec 2009 | B2 |
7637950 | Baccelli et al. | Dec 2009 | B2 |
7658752 | Labrom et al. | Feb 2010 | B2 |
7662187 | Zucherman et al. | Feb 2010 | B2 |
7666209 | Zucherman et al. | Feb 2010 | B2 |
7666228 | Le Couedic et al. | Feb 2010 | B2 |
7670377 | Zucherman et al. | Mar 2010 | B2 |
7682376 | Trieu | Mar 2010 | B2 |
7691146 | Zucherman et al. | Apr 2010 | B2 |
7695513 | Zucherman et al. | Apr 2010 | B2 |
7699852 | Frankel et al. | Apr 2010 | B2 |
7699873 | Stevenson et al. | Apr 2010 | B2 |
7727233 | Blackwell et al. | Jun 2010 | B2 |
7727241 | Gorensek et al. | Jun 2010 | B2 |
7742795 | Stone et al. | Jun 2010 | B2 |
7749231 | Bonvallet et al. | Jul 2010 | B2 |
7749252 | Zucherman et al. | Jul 2010 | B2 |
7749253 | Zucherman et al. | Jul 2010 | B2 |
7753938 | Aschmann et al. | Jul 2010 | B2 |
7758619 | Zucherman et al. | Jul 2010 | B2 |
7758647 | Arnin et al. | Jul 2010 | B2 |
7763028 | Lim et al. | Jul 2010 | B2 |
7763050 | Winslow et al. | Jul 2010 | B2 |
7763051 | Labrom et al. | Jul 2010 | B2 |
7763073 | Hawkins et al. | Jul 2010 | B2 |
7763074 | Altarac et al. | Jul 2010 | B2 |
7766967 | Francis | Aug 2010 | B2 |
7776090 | Winslow et al. | Aug 2010 | B2 |
7780709 | Bruneau et al. | Aug 2010 | B2 |
7789898 | Peterman | Sep 2010 | B2 |
7794476 | Wisnewski | Sep 2010 | B2 |
7803190 | Zucherman et al. | Sep 2010 | B2 |
7806911 | Peckham | Oct 2010 | B2 |
7811308 | Arnin et al. | Oct 2010 | B2 |
7811322 | Arnin et al. | Oct 2010 | B2 |
7811323 | Arnin et al. | Oct 2010 | B2 |
7811324 | Arnin et al. | Oct 2010 | B2 |
7811330 | Arnin et al. | Oct 2010 | B2 |
7819921 | Grotz | Oct 2010 | B2 |
7828822 | Zucherman et al. | Nov 2010 | B2 |
7828849 | Lim | Nov 2010 | B2 |
7833272 | Arnin et al. | Nov 2010 | B2 |
7837688 | Boyer, II et al. | Nov 2010 | B2 |
7837711 | Bruneau et al. | Nov 2010 | B2 |
7837734 | Zucherman et al. | Nov 2010 | B2 |
7846183 | Blain | Dec 2010 | B2 |
7846185 | Carls et al. | Dec 2010 | B2 |
7846186 | Taylor | Dec 2010 | B2 |
7857815 | Zucherman et al. | Dec 2010 | B2 |
7862569 | Zucherman et al. | Jan 2011 | B2 |
7862586 | Malek | Jan 2011 | B2 |
7862590 | Lim et al. | Jan 2011 | B2 |
7862592 | Peterson et al. | Jan 2011 | B2 |
7862615 | Carli et al. | Jan 2011 | B2 |
7867276 | Matge et al. | Jan 2011 | B2 |
7871426 | Chin et al. | Jan 2011 | B2 |
7955392 | Dewey et al. | Jun 2011 | B2 |
8012207 | Kim | Sep 2011 | B2 |
8025684 | Garcia-Bengochea et al. | Sep 2011 | B2 |
8057513 | Kohm et al. | Nov 2011 | B2 |
8062332 | Cunningham et al. | Nov 2011 | B2 |
8123782 | Altarac et al. | Feb 2012 | B2 |
8123807 | Kim | Feb 2012 | B2 |
8128662 | Altarac et al. | Mar 2012 | B2 |
8152837 | Altarac et al. | Apr 2012 | B2 |
8167944 | Kim | May 2012 | B2 |
8226690 | Altarac et al. | Jul 2012 | B2 |
8273108 | Altarac et al. | Sep 2012 | B2 |
8277488 | Altarac et al. | Oct 2012 | B2 |
8292922 | Altarac et al. | Oct 2012 | B2 |
8317864 | Kim | Nov 2012 | B2 |
8409282 | Kim | Apr 2013 | B2 |
8425559 | Tebbe et al. | Apr 2013 | B2 |
8613747 | Altarac et al. | Dec 2013 | B2 |
8628574 | Altarac et al. | Jan 2014 | B2 |
8740948 | Reglos et al. | Jun 2014 | B2 |
8845726 | Tebbe et al. | Sep 2014 | B2 |
8864828 | Altarac et al. | Oct 2014 | B2 |
8900271 | Kim | Dec 2014 | B2 |
8945183 | Altarac et al. | Feb 2015 | B2 |
9023084 | Kim | May 2015 | B2 |
9039742 | Altarac et al. | May 2015 | B2 |
20010031965 | Zucherman et al. | Oct 2001 | A1 |
20020143331 | Zucherman et al. | Oct 2002 | A1 |
20030040746 | Mitchell et al. | Feb 2003 | A1 |
20030074075 | Thomas et al. | Apr 2003 | A1 |
20030149438 | Nichols et al. | Aug 2003 | A1 |
20030153976 | Cauthen et al. | Aug 2003 | A1 |
20030176921 | Lawson | Sep 2003 | A1 |
20030220643 | Ferree | Nov 2003 | A1 |
20030220650 | Major et al. | Nov 2003 | A1 |
20040087947 | Lim et al. | May 2004 | A1 |
20040167625 | Beyar et al. | Aug 2004 | A1 |
20040220568 | Zucherman et al. | Nov 2004 | A1 |
20050049708 | Atkinson et al. | Mar 2005 | A1 |
20050075634 | Zucherman et al. | Apr 2005 | A1 |
20050101955 | Zucherman et al. | May 2005 | A1 |
20050125066 | McAfee | Jun 2005 | A1 |
20050143738 | Zucherman et al. | Jun 2005 | A1 |
20050165398 | Reiley | Jul 2005 | A1 |
20050192586 | Zucherman et al. | Sep 2005 | A1 |
20050192671 | Bao et al. | Sep 2005 | A1 |
20050209603 | Zucherman et al. | Sep 2005 | A1 |
20050216087 | Zucherman et al. | Sep 2005 | A1 |
20050228383 | Zucherman et al. | Oct 2005 | A1 |
20050228384 | Zucherman et al. | Oct 2005 | A1 |
20050228426 | Campbell | Oct 2005 | A1 |
20050245937 | Winslow | Nov 2005 | A1 |
20050261768 | Trieu | Nov 2005 | A1 |
20050278036 | Leonard et al. | Dec 2005 | A1 |
20060036258 | Zucherman et al. | Feb 2006 | A1 |
20060064165 | Zucherman et al. | Mar 2006 | A1 |
20060064166 | Zucherman et al. | Mar 2006 | A1 |
20060074431 | Sutton et al. | Apr 2006 | A1 |
20060084976 | Borgstrom et al. | Apr 2006 | A1 |
20060084983 | Kim | Apr 2006 | A1 |
20060084985 | Kim | Apr 2006 | A1 |
20060084988 | Kim | Apr 2006 | A1 |
20060084991 | Borgstrom et al. | Apr 2006 | A1 |
20060085069 | Kim | Apr 2006 | A1 |
20060085070 | Kim | Apr 2006 | A1 |
20060085074 | Raiszadeh | Apr 2006 | A1 |
20060089718 | Zucherman et al. | Apr 2006 | A1 |
20060102269 | Uchida et al. | May 2006 | A1 |
20060122620 | Kim | Jun 2006 | A1 |
20060149254 | Lauryssen et al. | Jul 2006 | A1 |
20060149289 | Winslow et al. | Jul 2006 | A1 |
20060167416 | Mathis et al. | Jul 2006 | A1 |
20060195102 | Malandain | Aug 2006 | A1 |
20060217811 | Lambrecht et al. | Sep 2006 | A1 |
20060224159 | Anderson | Oct 2006 | A1 |
20060235386 | Anderson | Oct 2006 | A1 |
20060241597 | Mitchell et al. | Oct 2006 | A1 |
20060241614 | Bruneau et al. | Oct 2006 | A1 |
20060241757 | Anderson | Oct 2006 | A1 |
20060247623 | Anderson et al. | Nov 2006 | A1 |
20060247632 | Winslow et al. | Nov 2006 | A1 |
20060247633 | Winslow et al. | Nov 2006 | A1 |
20060247650 | Yerby et al. | Nov 2006 | A1 |
20060247773 | Stamp | Nov 2006 | A1 |
20060264938 | Zucherman et al. | Nov 2006 | A1 |
20060264939 | Zucherman et al. | Nov 2006 | A1 |
20060265066 | Zucherman et al. | Nov 2006 | A1 |
20060265067 | Zucherman et al. | Nov 2006 | A1 |
20060271044 | Petrini et al. | Nov 2006 | A1 |
20060271049 | Zucherman et al. | Nov 2006 | A1 |
20060271055 | Thramann | Nov 2006 | A1 |
20060271061 | Beyar et al. | Nov 2006 | A1 |
20060271194 | Zucherman et al. | Nov 2006 | A1 |
20060276801 | Yerby et al. | Dec 2006 | A1 |
20060276897 | Winslow et al. | Dec 2006 | A1 |
20060282077 | Labrom et al. | Dec 2006 | A1 |
20060282078 | Labrom et al. | Dec 2006 | A1 |
20070016196 | Winslow et al. | Jan 2007 | A1 |
20070032790 | Aschmann et al. | Feb 2007 | A1 |
20070055237 | Edidin et al. | Mar 2007 | A1 |
20070055246 | Zucherman et al. | Mar 2007 | A1 |
20070073289 | Kwak et al. | Mar 2007 | A1 |
20070100340 | Lange et al. | May 2007 | A1 |
20070100366 | Dziedzic et al. | May 2007 | A1 |
20070123863 | Winslow et al. | May 2007 | A1 |
20070123904 | Stad et al. | May 2007 | A1 |
20070161991 | Altarac et al. | Jul 2007 | A1 |
20070161993 | Lowery et al. | Jul 2007 | A1 |
20070173818 | Hestad et al. | Jul 2007 | A1 |
20070173821 | Trieu | Jul 2007 | A1 |
20070173822 | Bruneau et al. | Jul 2007 | A1 |
20070173823 | Dewey et al. | Jul 2007 | A1 |
20070173832 | Tebbe et al. | Jul 2007 | A1 |
20070173939 | Kim et al. | Jul 2007 | A1 |
20070179500 | Chin et al. | Aug 2007 | A1 |
20070185490 | Implicito | Aug 2007 | A1 |
20070191948 | Arnin et al. | Aug 2007 | A1 |
20070198045 | Morton et al. | Aug 2007 | A1 |
20070198091 | Boyer et al. | Aug 2007 | A1 |
20070203493 | Zucherman et al. | Aug 2007 | A1 |
20070203495 | Zucherman et al. | Aug 2007 | A1 |
20070203496 | Zucherman et al. | Aug 2007 | A1 |
20070203497 | Zucherman et al. | Aug 2007 | A1 |
20070203501 | Zucherman et al. | Aug 2007 | A1 |
20070208345 | Marnay et al. | Sep 2007 | A1 |
20070208346 | Marnay et al. | Sep 2007 | A1 |
20070208366 | Pellegrino et al. | Sep 2007 | A1 |
20070225706 | Clark et al. | Sep 2007 | A1 |
20070225724 | Edmond | Sep 2007 | A1 |
20070225807 | Phan et al. | Sep 2007 | A1 |
20070225814 | Atkinson et al. | Sep 2007 | A1 |
20070233068 | Bruneau et al. | Oct 2007 | A1 |
20070233074 | Anderson et al. | Oct 2007 | A1 |
20070233076 | Trieu | Oct 2007 | A1 |
20070233077 | Khalili | Oct 2007 | A1 |
20070233081 | Pasquet et al. | Oct 2007 | A1 |
20070233082 | Chin et al. | Oct 2007 | A1 |
20070233083 | Abdou | Oct 2007 | A1 |
20070233084 | Betz et al. | Oct 2007 | A1 |
20070233088 | Edmond | Oct 2007 | A1 |
20070233089 | DiPoto et al. | Oct 2007 | A1 |
20070233096 | Garcia-Bengochea | Oct 2007 | A1 |
20070233098 | Mastrorio et al. | Oct 2007 | A1 |
20070233129 | Bertagnoli et al. | Oct 2007 | A1 |
20070250060 | Anderson et al. | Oct 2007 | A1 |
20070260245 | Malandain et al. | Nov 2007 | A1 |
20070265623 | Malandain et al. | Nov 2007 | A1 |
20070265624 | Zucherman et al. | Nov 2007 | A1 |
20070265625 | Zucherman et al. | Nov 2007 | A1 |
20070265626 | Seme | Nov 2007 | A1 |
20070270822 | Heinz | Nov 2007 | A1 |
20070270823 | Trieu et al. | Nov 2007 | A1 |
20070270824 | Lim et al. | Nov 2007 | A1 |
20070270826 | Trieu et al. | Nov 2007 | A1 |
20070270827 | Lim et al. | Nov 2007 | A1 |
20070270828 | Bruneau et al. | Nov 2007 | A1 |
20070270829 | Carls et al. | Nov 2007 | A1 |
20070270834 | Bruneau et al. | Nov 2007 | A1 |
20070272259 | Allard et al. | Nov 2007 | A1 |
20070276368 | Trieu et al. | Nov 2007 | A1 |
20070276369 | Allard et al. | Nov 2007 | A1 |
20070276372 | Malandain et al. | Nov 2007 | A1 |
20070276373 | Malandain | Nov 2007 | A1 |
20070276493 | Malandain et al. | Nov 2007 | A1 |
20070276496 | Lange et al. | Nov 2007 | A1 |
20070276497 | Anderson | Nov 2007 | A1 |
20070276500 | Zucherman et al. | Nov 2007 | A1 |
20080015700 | Zucherman et al. | Jan 2008 | A1 |
20080021468 | Zucherman et al. | Jan 2008 | A1 |
20080021560 | Zucherman et al. | Jan 2008 | A1 |
20080021561 | Zucherman et al. | Jan 2008 | A1 |
20080027545 | Zucherman et al. | Jan 2008 | A1 |
20080027552 | Zucherman et al. | Jan 2008 | A1 |
20080027553 | Zucherman et al. | Jan 2008 | A1 |
20080033445 | Zucherman et al. | Feb 2008 | A1 |
20080033553 | Zucherman et al. | Feb 2008 | A1 |
20080033558 | Zucherman et al. | Feb 2008 | A1 |
20080033559 | Zucherman et al. | Feb 2008 | A1 |
20080039853 | Zucherman et al. | Feb 2008 | A1 |
20080039858 | Zucherman et al. | Feb 2008 | A1 |
20080039859 | Zucherman et al. | Feb 2008 | A1 |
20080039945 | Zucherman et al. | Feb 2008 | A1 |
20080039946 | Zucherman et al. | Feb 2008 | A1 |
20080039947 | Zucherman et al. | Feb 2008 | A1 |
20080045958 | Zucherman et al. | Feb 2008 | A1 |
20080045959 | Zucherman et al. | Feb 2008 | A1 |
20080046081 | Zucherman et al. | Feb 2008 | A1 |
20080046085 | Zucherman et al. | Feb 2008 | A1 |
20080046086 | Zucherman et al. | Feb 2008 | A1 |
20080046087 | Zucherman et al. | Feb 2008 | A1 |
20080046088 | Zucherman et al. | Feb 2008 | A1 |
20080051785 | Zucherman et al. | Feb 2008 | A1 |
20080051898 | Zucherman et al. | Feb 2008 | A1 |
20080051899 | Zucherman et al. | Feb 2008 | A1 |
20080051904 | Zucherman et al. | Feb 2008 | A1 |
20080051905 | Zucherman et al. | Feb 2008 | A1 |
20080058806 | Klyce et al. | Mar 2008 | A1 |
20080058807 | Klyce et al. | Mar 2008 | A1 |
20080058808 | Klyce et al. | Mar 2008 | A1 |
20080058941 | Zucherman et al. | Mar 2008 | A1 |
20080065086 | Zucherman et al. | Mar 2008 | A1 |
20080065212 | Zucherman et al. | Mar 2008 | A1 |
20080065213 | Zucherman et al. | Mar 2008 | A1 |
20080065214 | Zucherman et al. | Mar 2008 | A1 |
20080071280 | Winslow | Mar 2008 | A1 |
20080071378 | Zucherman et al. | Mar 2008 | A1 |
20080086212 | Zucherman et al. | Apr 2008 | A1 |
20080108990 | Mitchell et al. | May 2008 | A1 |
20080114455 | Lange et al. | May 2008 | A1 |
20080132952 | Malandain et al. | Jun 2008 | A1 |
20080167655 | Wang et al. | Jul 2008 | A1 |
20080167656 | Zucherman et al. | Jul 2008 | A1 |
20080172057 | Zucherman et al. | Jul 2008 | A1 |
20080177272 | Zucherman et al. | Jul 2008 | A1 |
20080183210 | Zucherman et al. | Jul 2008 | A1 |
20080188895 | Cragg et al. | Aug 2008 | A1 |
20080208344 | Kilpela et al. | Aug 2008 | A1 |
20080215058 | Zucherman et al. | Sep 2008 | A1 |
20080221692 | Zucherman et al. | Sep 2008 | A1 |
20080228225 | Trautwein et al. | Sep 2008 | A1 |
20080234824 | Youssef et al. | Sep 2008 | A1 |
20080288075 | Zucherman et al. | Nov 2008 | A1 |
20080319550 | Altarac et al. | Dec 2008 | A1 |
20090118833 | Hudgins et al. | May 2009 | A1 |
20090125030 | Tebbe et al. | May 2009 | A1 |
20090138046 | Altarac et al. | May 2009 | A1 |
20090138055 | Altarac et al. | May 2009 | A1 |
20090222043 | Altarac et al. | Sep 2009 | A1 |
20090248079 | Kwak et al. | Oct 2009 | A1 |
20090292315 | Trieu | Nov 2009 | A1 |
20100042217 | Zucherman et al. | Feb 2010 | A1 |
20100082108 | Zucherman et al. | Apr 2010 | A1 |
20100131009 | Roebling et al. | May 2010 | A1 |
20100234889 | Hess | Sep 2010 | A1 |
20100262243 | Zucherman et al. | Oct 2010 | A1 |
20100280551 | Pool et al. | Nov 2010 | A1 |
20100305611 | Zucherman et al. | Dec 2010 | A1 |
20110313457 | Reglos et al. | Dec 2011 | A1 |
20120078301 | Hess | Mar 2012 | A1 |
20120158063 | Altarac et al. | Jun 2012 | A1 |
20120226315 | Altarac et al. | Sep 2012 | A1 |
20130012998 | Altarac et al. | Jan 2013 | A1 |
20130150886 | Altarac et al. | Jun 2013 | A1 |
20130165974 | Kim | Jun 2013 | A1 |
20130165975 | Tebbe et al. | Jun 2013 | A1 |
20130172932 | Altarac et al. | Jul 2013 | A1 |
20130172933 | Altarac et al. | Jul 2013 | A1 |
20130289622 | Kim | Oct 2013 | A1 |
20140081332 | Altarac et al. | Mar 2014 | A1 |
20140214082 | Reglos et al. | Jul 2014 | A1 |
20140228884 | Altarac et al. | Aug 2014 | A1 |
Number | Date | Country |
---|---|---|
268461 | Feb 1927 | CA |
69507480 | Sep 1999 | DE |
322334 | Jun 1989 | EP |
0767636 | Apr 1997 | EP |
0768843 | Apr 1997 | EP |
0959792 | Dec 1999 | EP |
1027004 | Aug 2000 | EP |
1030615 | Aug 2000 | EP |
1138268 | Oct 2001 | EP |
1330987 | Jul 2003 | EP |
1056408 | Dec 2003 | EP |
1343424 | Sep 2004 | EP |
1454589 | Sep 2004 | EP |
1148850 | Apr 2005 | EP |
1299042 | Mar 2006 | EP |
1578314 | May 2007 | EP |
1675535 | May 2007 | EP |
1861046 | Dec 2007 | EP |
2681525 | Mar 1993 | FR |
2722980 | Feb 1996 | FR |
2816197 | May 2002 | FR |
2884136 | Oct 2006 | FR |
2888744 | Jan 2007 | FR |
988281 | Jan 1983 | SU |
WO-9404088 | Mar 1994 | WO |
WO-9426192 | Nov 1994 | WO |
WO-9525485 | Sep 1995 | WO |
WO-9531158 | Nov 1995 | WO |
WO-9600049 | Jan 1996 | WO |
WO-9829047 | Jul 1998 | WO |
WO-9921500 | May 1999 | WO |
WO-9921501 | May 1999 | WO |
WO-9942051 | Aug 1999 | WO |
WO-0013619 | Mar 2000 | WO |
WO-0044319 | Aug 2000 | WO |
WO-0044321 | Aug 2000 | WO |
WO-0128442 | Apr 2001 | WO |
WO-0191657 | Dec 2001 | WO |
WO-0191658 | Dec 2001 | WO |
WO-0203882 | Jan 2002 | WO |
WO-0207623 | Jan 2002 | WO |
WO-0207624 | Jan 2002 | WO |
WO-02051326 | Jul 2002 | WO |
WO-02067793 | Sep 2002 | WO |
WO-02071960 | Sep 2002 | WO |
WO-02076336 | Oct 2002 | WO |
WO-03007791 | Jan 2003 | WO |
WO-03007829 | Jan 2003 | WO |
WO-03008016 | Jan 2003 | WO |
WO-03015646 | Feb 2003 | WO |
WO-03024298 | Mar 2003 | WO |
WO-03045262 | Jun 2003 | WO |
WO-03099147 | Dec 2003 | WO |
WO-03101350 | Dec 2003 | WO |
WO-2004073533 | Sep 2004 | WO |
WO-2004110300 | Dec 2004 | WO |
WO-2005009300 | Feb 2005 | WO |
WO-2005013839 | Feb 2005 | WO |
WO-2005025461 | Mar 2005 | WO |
WO-2005041799 | May 2005 | WO |
WO-2005044152 | May 2005 | WO |
WO-2005055868 | Jun 2005 | WO |
WO-2005079672 | Sep 2005 | WO |
WO-2005086776 | Sep 2005 | WO |
WO-2005115261 | Dec 2005 | WO |
WO-2006033659 | Mar 2006 | WO |
WO-2006034423 | Mar 2006 | WO |
WO-2006039243 | Apr 2006 | WO |
WO-2006039260 | Apr 2006 | WO |
WO-2006045094 | Apr 2006 | WO |
WO-2006063047 | Jun 2006 | WO |
WO-2006064356 | Jun 2006 | WO |
WO-2006065774 | Jun 2006 | WO |
WO-2006089085 | Aug 2006 | WO |
WO-2006102269 | Sep 2006 | WO |
WO-2006102428 | Sep 2006 | WO |
WO-2006102485 | Sep 2006 | WO |
WO-2006107539 | Oct 2006 | WO |
WO-2006110462 | Oct 2006 | WO |
WO-2006110464 | Oct 2006 | WO |
WO-2006110767 | Oct 2006 | WO |
WO-2006113080 | Oct 2006 | WO |
WO-2006113406 | Oct 2006 | WO |
WO-2006113814 | Oct 2006 | WO |
WO-2006118945 | Nov 2006 | WO |
WO-2006119235 | Nov 2006 | WO |
WO-2006119236 | Nov 2006 | WO |
WO-2006135511 | Dec 2006 | WO |
WO-2007015028 | Feb 2007 | WO |
WO-2007035120 | Mar 2007 | WO |
WO-2007075375 | Jul 2007 | WO |
WO-2007075788 | Jul 2007 | WO |
WO-2007075791 | Jul 2007 | WO |
WO-2007089605 | Aug 2007 | WO |
WO-2007089905 | Aug 2007 | WO |
WO-2007089975 | Aug 2007 | WO |
WO-2007097735 | Aug 2007 | WO |
WO-2007109402 | Sep 2007 | WO |
WO-2007110604 | Oct 2007 | WO |
WO-2007111795 | Oct 2007 | WO |
WO-2007111979 | Oct 2007 | WO |
WO-2007111999 | Oct 2007 | WO |
WO-2007117882 | Oct 2007 | WO |
WO-2007121070 | Oct 2007 | WO |
WO-2007127550 | Nov 2007 | WO |
WO-2007127588 | Nov 2007 | WO |
WO-2007127677 | Nov 2007 | WO |
WO-2007127689 | Nov 2007 | WO |
WO-2007127694 | Nov 2007 | WO |
WO-2007127734 | Nov 2007 | WO |
WO-2007127736 | Nov 2007 | WO |
WO-2007131165 | Nov 2007 | WO |
WO-2007134113 | Nov 2007 | WO |
WO-2008009049 | Jan 2008 | WO |
WO-2008048645 | Apr 2008 | WO |
WO-2008057506 | May 2008 | WO |
WO-2008130564 | Oct 2008 | WO |
WO-2009014728 | Jan 2009 | WO |
WO-2009033093 | Mar 2009 | WO |
WO-2009086010 | Jul 2009 | WO |
WO-2009091922 | Jul 2009 | WO |
WO-2009094463 | Jul 2009 | WO |
WO-2009114479 | Sep 2009 | WO |
WO-2011084477 | Jul 2011 | WO |
Entry |
---|
European Search Report Application No. EP05849654.8; Applicant: The Board of Trustees of the Leland Stanford Junior University; Date of Completion: Jun. 21, 2011, 4 pages. |
International Search Report and Written Opinion; Application No. PCT/US2005/038026; Mailing Date: Apr. 22, 2008, 9 pages. |
International Search Report and Written Opinion; Application No. PCT/US2005/044256; Mailing Date: Jul. 28, 2006, 7 pages. |
International Search Report and Written Opinion; Application No. PCT/US2006/047824; Mailing Date: Oct. 16, 2008, 17 pages. |
International Search Report and Written Opinion; Application No. PCT/US2006/048611; Mailing Date: Oct. 14, 2008; 10 pages. |
International Search Report and Written Opinion; Application No. PCT/US2006/048614; Mailing Date: Feb. 3, 2006; 23 pages. |
International Search Report and Written Opinion; Application No. PCT/US2007/022171; Mailing Date: Apr. 15, 2008, 9 pages. |
International Search Report and Written Opinion; Application No. PCT/US2007/023312; Mailing Date: May 22, 2008, 14 pages. |
International Search Report and Written Opinion; Application No. PCT/US2008/004901; Mailing Date: Aug. 19, 2008, 7 pages. |
International Search Report and Written Opinion; Application No. PCT/US2008/008382; Mailing Date: Mar. 2, 2009, 13 pages. |
International Search Report and Written Opinion; Application No. PCT/US2008/008983; Mailing Date: Feb. 23, 2009, 7 pages. |
International Search Report and Written Opinion; Application No. PCT/US2008/075487; Mailing Date: Dec. 31, 2008, 7 pages. |
International Search Report and Written Opinion; Application No. PCT/US2008/087527; Mailing Date: Jul. 30, 2009, 10 pages. |
International Search Report and Written Opinion; Application No. PCT/US2009/031150; Mailing Date: Aug 28, 2009, 6 pages. |
International Search Report and Written Opinion; Application No. PCT/US2009/031710; Mailing Date: Sep. 1, 2009, 10 pages. |
Minns, R.J., et al., “Preliminary Design and Experimental Studies of a Novel Soft Implant for Correcting Sagittal Plane Instability in the Lumbar Spine,” (1997) Spine, 22(16): 1819-1827. |
Supplementary European Search Report; Application No. EP05849654.6; Applicant: Vertiflex, Inc.; Date of Completion: May 15, 2009, 10 pages. |
Supplementary European Search Report; Application No. EP07861426.0; Applicant: Vertiflex, Inc.; Date of Completion: Jun. 7, 2011, 6 pages. |
Supplementary European Search Report; Application No. EP07861721.4; Applicant: Vertiflex, Inc.; Date of Completion: Nov. 24, 2009, 6 pages. |
Supplementary European Search Report; Application No. EP09170304.1; Applicant: Vertiflex, Inc.; Date of Completion: Nov. 11, 2009, 5 pages. |
Supplementary European Search Report; Application No. EP09170338.9; Applicant: Vertiflex, Inc.; Date of Completion: Nov. 12, 2009, 6 pages. |
Supplementary European Search Report; Application No. EP09702116.6; Applicant: Vertiflex, Inc.; Date of Completion: Feb. 11, 2011, 6 pages. |
Supplementary European Search Report; Application No. EP11151901.3; Applicant: Vertiflex, Inc.; Date of Completion: Apr. 7, 2011, 6 pages. |
Swan, Colby, “Preliminary Design and Experimental Studies of a Novel Soft Implant for Correcting Sogittal Plane Instability in the Lumbar Spine,” Spine, 1997, 22(16), 1826-1827. |
Supplementary European Search Report; Application No. EP05815519.3; Applicant: The Board of Trustees of Leland Stanford Junior University; Date of Completion: Sep. 28, 2011, 9 pages. |
Supplementary European Search Report; Application No. EP05849654; Applicant: The Board of Trustees of Leland Stanford Junior University; Date of Completion: May 15, 2009, 5 pages. |
Australia Exam Report for Application No. AU2006329867, Applicant: The Board of Trustees of Leland Stanford Junior University; Date of Issue: Jan. 27, 2012, 2 pages. |
Australia Exam Report for Application No. AU2007317886, Applicant: VertiFlex, Inc.; Date of Issue: Jun. 18, 2012, 3 pages. |
Australia Exam Report for Application No. AU2008241447, Applicant: VertiFlex, Inc.; Date of Issue: Jul. 5, 2012, 4 pages. |
Australia Exam Report for Application No. AU2008275708, Applicant: VertiFlex, Inc.; Date of Issue: Nov. 12, 2012, 4 pages. |
Australia Exam Report for Application No. AU2008279680, Applicant: VertiFlex, Inc.; Date of Issue: Oct. 30, 2012, 5 pages. |
Australia Exam Report for Application No. AU2008296066, Applicant: VertiFlex, Inc.; Date of Issue: Mar. 6, 2013, 3 pages. |
Australia Exam Report for Application No. AU2008343092, Applicant: VertiFlex, Inc.; Date of Issue: Feb. 8, 2013, 4 pages. |
Australia Exam Report No. 2 for Application No. AU2009206098, Applicant: VertiFlex, Inc.; Date of Issue: Aug. 19, 2014, 4 pages. |
Canada Exam Report for Application No. CA2634251, Applicant: The Board of Trustees of Leland Stanford Junior University; Date of Issue: Dec. 3, 2013, 2 pages. |
Canada Exam Report for Application No. CA2668833, Applicant: Vertiflex, Inc.; Date of Issue: Dec. 5, 2013, 2 pages. |
Canada Exam Report for Application No. CA2695937, Applicant: Vertiflex, Inc.; Date of Issue: Aug. 7, 2014, 2 pages. |
Canada Exam Report for Application No. CA2697628, Applicant: Vertiflex, Inc.; Date of Issue: Oct. 16, 2014, 2 pages. |
Canada Exam Report for Application No. CA2698718, Applicant: Vertiflex, Inc.; Date of Issue: May 20, 2014, 3 pages. |
Supplementary European Search Report; Application No. EP06845480; Applicant: VertiFlex, Inc.; Date of Completion: Aug. 14, 2012, 9 pages. |
Supplementary European Search Report for Application No. EP13184922.6; Applicant: VertiFlex, Inc.; Date of Issue: Oct. 30, 2013, 8 pages. |
Supplementary European Search Report for Application No. EP07861426; Applicant: VertiFlex, Inc.; Date of Issue: Jun. 7, 2011, 6 pages. |
Supplementary European Search Report for Application No. EP07861721.4; Applicant: VertiFlex, Inc.; Date of Issue: Nov. 24, 2009, 6 pages. |
Supplementary European Search Report for Application No. EP09170304.1; Applicant: VertiFlex, Inc.; Date of Issue: Nov. 24, 2009, 5 pages. |
Supplementary European Search Report for Application No. EP09170338.9; Applicant: VertiFlex, Inc.; Date of Issue: Nov. 24, 2009, 6 pages. |
Supplementary European Search Report for Application No. EP11151901.3; Applicant: VertiFlex, Inc.; Date of Issue: Apr. 7, 2011, 6 pages. |
Supplementary European Search Report for Application No. EP08742949.4; Applicant: VertiFlex, Inc.; Date of Issue: Sep. 17, 2012, 6 pages. |
Supplementary European Search Report for Application No. EP08780034.8; Applicant: VertiFlex, Inc.; Date of Issue: Sep. 19, 2012, 7 pages. |
Supplementary European Search Report for Application No. EP08794704.0; Applicant: VertiFlex, Inc.; Date of Issue: Oct. 23, 2012, 9 pages. |
Supplementary European Search Report for Application No. EP08799267.3; Applicant: VertiFlex, Inc.; Date of Issue: Jun. 29, 2011, 7 pages. |
Supplementary European Search Report for Application No. EP08867282.9; Applicant: VertiFlex, Inc.; Date of Issue: Nov. 28, 2012, 10 pages. |
Supplementary European Search Report for Application No. EP09702116.6; Applicant: VertiFlex, Inc.; Date of Issue: Feb. 11, 2011, 7 pages. |
International Search Report and Written Opinion; Application No. PCT/US2010/060498; Mailing Date: Aug. 25, 2011, 17 pages. |
International Search Report and Written Opinion; Application No. PCT/US2009/036561; Mailing Date: Sep. 17, 2009, 12 pages. |
Australia Exam Report for Application No. AU2009223607, Applicant: VertiFlex, Inc.; Date of Issue: Jun. 4, 2013, 3 pages. |
Number | Date | Country | |
---|---|---|---|
20130165975 A1 | Jun 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11593995 | Nov 2006 | US |
Child | 13776630 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11582874 | Oct 2006 | US |
Child | 11593995 | US | |
Parent | 11314712 | Dec 2005 | US |
Child | 11582874 | US | |
Parent | 11190496 | Jul 2005 | US |
Child | 11314712 | US | |
Parent | 11079006 | Mar 2005 | US |
Child | 11190496 | US | |
Parent | 11052002 | Feb 2005 | US |
Child | 11079006 | US | |
Parent | 11006502 | Dec 2004 | US |
Child | 11052002 | US | |
Parent | 10970843 | Oct 2004 | US |
Child | 11006502 | US |